Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Harpoon Therapeutics Inc (HARP)

Harpoon Therapeutics Inc (HARP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month

Investors are still excited about obesity treatments and weight-management drugs.

MRK : 98.58 (-2.13%)
LLY : 818.86 (-1.63%)
NVO : 107.06 (-1.86%)
HARP : 23.01 (+0.09%)
This 1 Bullish Move by Merck Could Drive Growth for Years to Come

It's buying a company with sophisticated biotechnology platforms that could drive lots of growth -- eventually.

AMGN : 298.84 (-7.14%)
MRK : 98.58 (-2.13%)
HARP : 23.01 (+0.09%)
Boeing, Alaska Air Group fall; Harpoon Therapeutics, Axonics rise, Monday, 1/8/2024

Stocks that traded heavily or had substantial price changes on Monday: Boeing, Alaska Air Group fall; Harpoon Therapeutics, Axonics rise

HARP : 23.01 (+0.09%)
ANSS : 344.48 (-0.53%)
MKKGY : 32.1200 (-1.11%)
ALK : 51.45 (-0.77%)
BA : 145.17 (-2.54%)
Stocks Set to Open Lower as Investors Await Key U.S. Inflation Data and Big Tech Earnings

December S&P 500 futures (ESZ23) are down -0.76%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.92% this morning as the benchmark U.S. 10-year yield hit 5% for the first time since 2007 while...

ESZ23 : 4,694.27s (-0.58%)
NQZ23 : 16,530.23s (-0.07%)
SEDG : 12.24 (-10.53%)
AXP : 288.51 (-1.52%)
RF : 26.18 (-0.08%)
KNX : 56.45 (-4.13%)
MSFT : 423.03 (+1.20%)
GOOGL : 181.62 (+0.70%)
V : 309.85 (-0.15%)
KO : 63.20 (-0.25%)
META : 584.82 (+0.28%)
BA : 145.17 (-2.54%)
MarketBeat: Week in Review 12/12 - 12/16

A triple-witching day means it could be a rough end to a trading week. Before you step away for the holidays, here are some of the top articles from this week.

BILI : 21.08 (-7.34%)
PLAY : 40.60 (-0.81%)
MULN : 2.9800 (+74.27%)
NVDA : 148.29 (+2.09%)
AMD : 143.63 (-2.52%)
LULU : 320.90 (+0.77%)
TSCO : 279.19 (-0.85%)
HARP : 23.01 (+0.09%)
KSS : 18.26 (-2.30%)
Harpoon Therapeutics Remains Volatile After Promising News

Harpoon Therapeutics offers an example of biotech's volatility. The stock advanced as much as 191% intraday Monday before settling down to a gain of 22.61%.

HARP : 23.01 (+0.09%)
AMGN : 298.84 (-7.14%)
GILD : 94.35 (-2.76%)
REGN : 821.00 (-0.57%)
VRTX : 490.00 (-2.34%)
MRNA : 43.47 (+1.68%)
ABBV : 171.09 (-1.91%)
Three Small-Cap Biotech Stocks to Consider Now

This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023 

HARP : 23.01 (+0.09%)
HTGM : 0.4800 (-20.00%)
ABEO : 6.11 (-4.98%)
Harpoon Therapeutics (NASDAQ: HARP) Releases Updated Phase 1 Interim Results for HPN217 in Treating Relapsed Multiple Myeloma

Harpoon Therapeutics, Inc. (NASDAQ: HARP) is engaged as a clinical-stage immune-oncology company, which is focused on the research and development

HARP : 23.01 (+0.09%)
Pre-Market Brief: Stocks Mixed As Investors Await Inflation Data, Fed meeting

December S&P 500 futures (ESZ22) are trending up +0.26% this morning after three major US benchmark indices closed lower on Friday, notching their biggest weekly drop in more than a month, as hotter-than-anticipated...

ESZ22 : 3,871.47s (-0.66%)
HARP : 23.01 (+0.09%)
HZNP : 116.30 (+0.04%)
AMGN : 298.84 (-7.14%)
GPC : 122.70 (+0.28%)
RH : 333.43 (+1.06%)
ULTA : 379.79 (-0.20%)
LI : 22.61 (-7.07%)
Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Presented encouraging interim data for anti-DLL3 T cell engager HPN328 from ongoing dose escalation clinical trial at the 2022 ASCO Annual Meeting ...

HARP : 23.01 (+0.09%)

Barchart Exclusives

1 Dividend Aristocrat to Bet on Trump's Tariffs and the Fed's Rate Cuts
Nucor is one stock that stands to benefit from the Fed's rate cuts as well as any possible tariffs under a Trump administration. It is also a dividend aristocrat, and has increased its payouts for over 5 decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar